| Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic M Hibicke, G Billac, CD Nichols Psychedelic Medicine 2 (1), 10-14, 2024 | | 2024 |
| Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression TW Flanagan, TP Foster, TE Galbato, PY Lum, B Louie, G Song, ... ACS Pharmacology & Translational Science 7 (2), 478-492, 2024 | 1 | 2024 |
| The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents AA Jensen, CR Cecchi, M Hibicke, AH Bach, E Kaadt, E Marcher-Rorsted, ... bioRxiv, 2024.04. 19.590212, 2024 | | 2024 |
| 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk? HM Dourron, CD Nichols, O Simonsson, M Bradley, R Carhart-Harris, ... Psychopharmacology, 1-23, 2023 | 5 | 2023 |
| If Everything Is Psychedelic, Then Nothing Is: A Response to O'Donnell et al. and Lepow et al. DE Nichols, PS Hendricks, CD Nichols Psychedelic Medicine 1 (4), 195-197, 2023 | | 2023 |
| Compositions and methods for treating ocular pathologies TP Foster, CD Nichols US Patent 11,759,438, 2023 | | 2023 |
| Method of treatment for psilocybin or psilocin infusion RS Bridges, JC CLIFTON, JB Clifton, N Family, EL Maillet, RAZ Shlomi, ... US Patent App. 18/015,277, 2023 | | 2023 |
| Compositions and methods to reduce pathogenesis TP Foster, CD Nichols US Patent App. 17/984,011, 2023 | | 2023 |
| The Elephant in the Room: Personal use of psychedelics among psychedelic researchers PS Hendricks, CD Nichols Psychedelic Medicine 1 (3), 122-123, 2023 | 2 | 2023 |
| Psychedelic commercialization: A wide-spanning overview of the emerging psychedelic industry JS Aday, BS Barnett, D Grossman, KS Murnane, CD Nichols, ... Psychedelic Medicine 1 (3), 150-165, 2023 | 12 | 2023 |
| Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders AB Wulff, CD Nichols, SM Thompson Neuropharmacology 231, 109504, 2023 | 11 | 2023 |
| CONDITIONED PLACE AVOIDANCE IS ASSOCIATED A DISTINCT HIPPOCAMPAL PHENOTYPE, ALTERED PATTERN SEPARATION, AND REDUCED ROS PRODUCTION DP Kelley, L Albrechet-Souza, S Cruise, R Maiya, A Destouni, ... PSYCHOSOMATIC MEDICINE 85 (4), A67-A67, 2023 | | 2023 |
| Conditioned place avoidance is associated with a distinct hippocampal phenotype, partly preserved pattern separation, and reduced reactive oxygen species production after stress DP Kelley, L Albrechet‐Souza, S Cruise, R Maiya, A Destouni, ... Genes, Brain and Behavior 22 (2), e12840, 2023 | 1 | 2023 |
| A single administration of psilocybin persistently rescues cognitive deficits caused by adolescent chronic restraint stress without long-term changes in synaptic protein gene … M Hibicke, HM Kramer, CD Nichols Psychedelic Medicine 1 (1), 54-67, 2023 | 8 | 2023 |
| Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion PS Hendricks, CD Nichols, KA Cunningham, MA Geyer, R Griffiths, ... Psychedelic Medicine 1 (1), 2-11, 2023 | 3 | 2023 |
| Proposed consensus statement on defining psychedelic drugs DE Nichols, CD Nichols, PS Hendricks Psychedelic Medicine 1 (1), 12-13, 2023 | 17 | 2023 |
| Editors' Introduction to Psychedelic Medicine PS Hendricks, CD Nichols Psychedelic Medicine 1 (1), 1-1, 2023 | | 2023 |
| Serotonin receptors CD Nichols Primer on the Autonomic Nervous System, 89-92, 2023 | 1 | 2023 |
| A Single Administration of a Psychedelic Can Persistently Change Synaptic Function Through 5-HT2A Receptor Activation in Rats C Nichols, M Hibicke, J Middleton, H Kramer, J Kristensen NEUROPSYCHOPHARMACOLOGY 47 (SUPPL 1), 266-266, 2022 | | 2022 |
| The Ca2+/CaM, Src kinase and/or PI3K-dependent EGFR transactivation via 5-HT2A and 5-HT1B receptor subtypes mediates 5-HT-induced vasoconstriction S Guner, T Akhayeva, CD Nichols, H Gurdal Biochemical Pharmacology 206, 115317, 2022 | | 2022 |
